alexa Basavaraj Binjawadagi | The Ohio State University

Journal of Clinical & Experimental Neuroimmunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Basavaraj Binjawadagi

Basavaraj Binjawadagi Basavaraj Binjawadagi
Ohio state university

Dr. Basavaraj Binjawadagi obtained his degree in veterinary medicine (BVSc & AH) (2000) from the university of agricultural sciences (UAS), Dharwad, and MVSc in veterinary microbiology (2007) from Karnataka veterinary, animal and fisheries sciences university (KVAFSU), Bidar, India. He gained eight years of professional experience in poultry health consultancy and government veterinary/animal husbandry service. Further, he pursued MS (2012) and PhD (2015) in comparative and veterinary medicine (CVM) from the Ohio state university (OSU), Wooster, OH, under the supervision of Dr. Renukaradhya Gourapura. During his graduate studies, he worked on development of novel, biodegradable PLGA nanoparticle based mucosal inactivated vaccine and virus like particles (VLPs) vaccine against an economically important swine viral disease, porcine reproductive and respiratory syndrome. Presently he is working as postdoctoral researcher at the department of veterinary biosciences, OSU, Columbus, OH, under the supervision of Dr. Stefan Niewiesk, focusing on maternal immunization, and maternal antibodies interference to immunizations and novel anti-viral vaccine development with special focus on respiratory syncytial virus (RSV).

Research Interest

Development of maternal immunization strategies to prevent viral diseases in children below one year, Understanding the role of maternally derived antibodies in neonatal immunity and interference to immunization, Development of novel mucosal vaccines and vaccination strategies against RSV and other viral diseases, Mucosal adjuvants screening for mucosal anti-viral vaccines, PLGA nanoparticle entrapped vaccines for anti-viral vaccines, VLPs technology based vaccines against viral diseases


Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version